Value-Based Care Solutions: How to Evaluate Partners, Platforms, and Enablement Companies

“Value-based care solutions” is a phrase that covers a lot of ground. It gets used for analytics dashboards, for point-of-care software, for companies that sign payor contracts on a practice’s behalf, and for management services organizations that run the back office. If you are comparing options, that spread is the first problem to solve, because you cannot evaluate a partner until you know which kind of partner you actually need.

This guide is for practices and provider organizations at that stage. It assumes you know what value-based care is and how the payment models work; if not, start with our comparison of fee-for-service vs value-based care and our explainer on what value-based contracting is. What follows is the part those articles do not cover: how to judge the companies offering to help.

The short version is that every question worth asking a value-based care partner comes back to one test. Does the partner make money when you succeed, or when you sign? Everything below is a way of getting an honest answer to that.

What Counts as a Value-Based Care Solution?

Four categories cover almost everything sold under this label. They overlap, and the more strategic partners span more than one, but naming them tells you what you are looking at.

Analytics and reporting platforms. Software that pulls together financial and clinical data, tracks performance against a benchmark, and reports on quality measures. Some are sold as standalone value-based care software; others come bundled with a partner. On their own, they tell you how you did. They do not change what happens in the exam room, and they do not bring a contract with them.

Point-of-care decision support. Technology that puts evidence-based guidance and cost visibility in front of the clinician at the moment a treatment decision is made. This is where performance is actually created, because contracts are settled on what happened during the year, one clinical choice at a time. Our explainer on point-of-care decision support covers how it works.

Enablement partners. Companies that supply the whole apparatus: the payor contracts, the benchmarking, the analytics, the technology, and in some arrangements the financial protection. This is what most people mean when they say value-based care company or value-based care partner. Our overview of the value-based care ecosystem explains where enablers sit between payors and providers.

Management services organizations. MSOs run operations: billing, credentialing, staffing, purchasing. Some also offer value-based care services, and some enablers also offer management services, which is why the terms blur. The distinction that matters is whether the organization is accountable for performance under a value-based contract or simply running your office.

People often ask which platforms stand out. The label matters less than the answers to the seven questions below. A dashboard from a company that carries none of the risk and a program from a company that carries all of it can look alike in a demo. They are not alike in an off year.

Build or Partner?

Most practices do not build this infrastructure themselves, and the reason is cost rather than capability. A working program needs a credible cost benchmark built from claims history, attribution rules that assign the right patients and costs to the right providers, analytics that run during the year rather than after it, and someone to negotiate and administer a contract with each payor. Our contracting explainer covers why every value-based contract depends on that machinery, and our guide to value-based care analytics goes deep on the data side.

Building all of it is a multi-year project with a payroll attached. Partnering trades that for a share of the savings. Whether the trade is a good one depends entirely on the partner.

The Evaluation Framework: Seven Questions to Ask Any Partner

Put these to every company on your list, in writing, and compare the answers side by side. Each question comes with what a good answer looks like and what a weak one sounds like.

1. Who carries the risk?

This comes first because everything else follows from it. Ask directly: if the program has an off year and costs come in above the benchmark, who pays? A partner that is confident in its own model does not need the practice to carry downside risk in order to participate. OMI’s programs, for example, are one-sided: practices share in savings and owe nothing when there are none.

The question is not theoretical. Medicare’s direction is toward downside risk. As of 2026, 82.8% of Shared Savings Program ACOs are in the two-sided risk tracks, the highest share since the program began, and CMS has finalized rule changes intended to move more organizations that way. From January 2027, the Ambulatory Specialty Model will hold selected specialists treating heart failure and low back pain financially accountable under a mandatory model, with Medicare Part B payment adjustments that range from a 9% cut to a 9% increase in the first payment year. As payors push risk down, the partner’s answer to this question decides whether that risk stops with them or lands on you.

Weak answer: “We share the upside and the downside together.” That sounds fair until you ask what your share of a $500,000 overrun would be.

2. What does it cost before it earns?

Some solutions charge implementation fees, monthly platform fees, or per-member charges from day one. Others are paid only from the savings a program generates. This is the plainest alignment test there is. A partner paid on participation gets paid whether or not you succeed. A partner paid from savings does not.

Good answer: no upfront cost and a clearly stated share of savings. Weak answer: a subscription fee justified by “the value of the data,” with the savings share on top.

3. Does the technology reach the exam room?

Contracts are reconciled after the fact, but performance is built during the year, in decisions about which drug, which imaging, and which follow-up interval. Retrospective reporting tells you what happened. Point-of-care support changes what happens. Ask to see, live, what a clinician sees at the moment of a treatment decision. If the answer is a quarterly PDF, the technology is not reaching the exam room.

4. How transparent is the data?

Ask whether you can see your own performance against the benchmark during the measurement period, not just at reconciliation, and whether you can see the cost data behind it. Good answer: a dashboard you control, refreshed on a known cadence, with the methodology explained. Weak answer: a report the partner produces, on the partner’s schedule, from a model the partner does not explain. If you cannot see the numbers moving, you cannot manage them.

5. Who does the contracting work?

One of the core jobs of an enablement partner is the payor relationship: negotiating the contract, setting the benchmark, administering attribution and reconciliation, and getting shared savings paid out on time. Ask which payors the partner already has agreements with, who at the partner administers them, and how disputes get resolved. A software vendor with no payor contracts is a tool, not a partner, and the contracting work will still be yours.

6. Does specialty matter to them?

Value-based care originated in primary care, and much of the tooling still assumes a primary care population. Specialty practices are different: episode-based rather than population-based, with smaller panels and condition-specific quality measures. Ask what the partner has actually run in your specialty, which measures it uses there, and how it handles the statistical noise of a small panel. Our guide to value-based care contracts for specialty providers explains why a primary care template applied to a specialty practice produces unfair benchmarks, and our executive guide to the specialty cost paradox explains why specialty care is where the spending, and the opportunity, sits.

7. What happens to quality?

Shared savings are typically gated on quality. Reduce costs and miss the quality standard, and you may forfeit some or all of the savings; in Medicare’s Shared Savings Program, meeting the quality performance standard is a condition of sharing in savings at all. So ask how the partner supports quality measure performance, not just cost reduction, and which measures apply to you. Our guide to value-based care quality measures explains how these are set. A partner focused only on cost is focused on half the contract.

Red Flags

Any one of these is worth a pause. Two or more is a reason to keep looking.

• Downside risk in year one. Losses pushed onto a small or specialty practice before there is any performance history to justify it.
• Fees due regardless of results. Large upfront charges or per-member fees that get paid whether or not the program generates savings.
• Black-box reporting. Numbers with no methodology, benchmarks with no explanation, and no access to the underlying data.
• Vague answers on attribution. If the partner cannot explain which patients and costs will be assigned to you and why, the reconciliation will surprise you.
• A primary care playbook for a specialty practice, with references only from other specialties.
• No payor relationships of its own. Software plus a promise to “support your negotiations” is not the same as a contract.

How to Run the Evaluation

Three habits make the comparison useful. Put the seven questions in writing and ask every candidate to answer in writing, because verbal answers are easier to soften. Ask for references from practices in your specialty, and ask those references about the off year rather than the good one. And ask to see a real performance report and a real point-of-care screen, with patient data masked if it must be. A demo built for a sales call tells you very little.

Where OMI Sits

We will answer our own questions. OMI’s programs run on a one-sided shared savings model: participating practices carry no upfront cost and no downside exposure. If a program generates savings, providers share in them. If it does not, there is nothing to pay back. OMI holds the payor contracts and administers benchmarking, attribution, and reconciliation, and the OMI PULSE platform supplies the point-of-care decision support and real-time performance reporting the programs run on. Our focus is specialty care, in ophthalmology, oncology, and rheumatology, with additional specialties in development. We are honest about fit: if your needs fall within areas that we don’t support, we will let you know. If you are a specialty practice, our programs were built to answer the questions on this list.

Common Questions

What is a value-based care enablement company?

A company that supplies the infrastructure a practice needs to take part in value-based contracts: typically the payor contracts, benchmarking, analytics, and technology, and in some cases the financial protection. Enablers sit between payors and providers, which our ecosystem article explains in more detail.

What is the difference between a value-based care platform and an enablement partner?

A platform is software. It measures and reports. An enablement partner is accountable for a program: it brings the contract, runs the administration, and usually supplies the platform as part of the package. The practical test is whether the company shares financially in the outcome. Most platforms do not.

Do value-based care solutions cost money upfront?

Some do. Analytics platforms are often sold on subscription, and some partners charge implementation or per-member fees. Others, including OMI, are paid from the savings a program generates and charge nothing upfront. The fee structure is one of the clearest signals of whether a partner’s incentives line up with yours.

How do value-based care companies get paid?

Through some combination of fees and a share of savings. A partner paid mostly from savings earns only when outcomes improve and costs come in below the benchmark. A partner paid mostly from fees earns either way. Ask for the split in writing. Our post on how physicians are actually paid in value-based care covers the provider side of the same question.

What is the difference between an enablement partner and an MSO?

A management services organization runs practice operations, such as billing, credentialing, and staffing. An enablement partner is accountable for performance under a value-based contract. Some organizations do both; OMI, for example, offers management services alongside its value-based care programs. The distinction that matters is accountability for the contract, not the label on the door.

Where to Go From Here

The step after choosing who to talk to is understanding the terms you will be offered. Our guide to value-based care contracts for specialty providers covers the six contract terms that most often hurt specialty practices. And if you would rather start by seeing how one partner answers the seven questions, the offer below is exactly that.